Thank you for downloading the white paper, "Synergizing Innovation and Protection: Strategies for Effective Collaboration Between R&D and IP in Pharma."

Spiro[2.3]hexanes are an example of promising yet challenging scaffold structures for new drug compounds. By using AI-powered predictive analytics with CAS BioFinder, researchers more efficiently identified candidates for validation.

AI-powered solutions hold so much potential for faster scientific innovation, but there are key milestones organizations must achieve before they can move beyond the pilot phase. These five markers are the cornerstones of AI readiness.

Point-of-care testing goes beyond pandemic-era viral infection tests to bring faster diagnostics for infectious diseases, chronic conditions, cancer, and more.